The cannabis world is abuzz with news about the latest federal Food & Drug Administration (FDA) report regarding cannabidiol (CBD). We break down what it is, and what it means for the industry and the regulatory landscape for...more
3/9/2020
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Corporate Counsel ,
Department of Health and Human Services (HHS) ,
E-Cigarettes ,
Enforcement Programs ,
Food and Drug Administration (FDA) ,
Information Reports ,
Regulatory Agencies ,
Regulatory Agenda
On October 7, 2019, the US Court of Appeals for the Second Circuit extended litigants’ ability to seek discovery under 28 U.S.C. §1782. Parties typically pursue discovery as part of the litigation process; however, Section...more
On January 7, 2019, the New York State Department of Financial Services (DFS or the “Department”) issued guidance regarding internal whistleblowing programs, calling a “robust” whistleblowing program an “essential component...more